The American Association of Clinical Endocrinologists and the American College of Endocrinology are seeking to eliminate the stigma surrounding the term "obesity" and clarify information about obesity as a disease state.
The natural curiosity provoked by looking at research and clinical care with a sense of wonder may help us find new ways to deal with old problems.
Keeping abreast of changing payment models and regulations is key to maximizing your practice's finances.
Katherine A. Roberts, MD, FACE, ECNU, discusses her experience with opting out of Medicare and offers advice to physicians considering doing the same.
Harpreet Bajaj, MD, MPH, ECNU, FACE, offers perspective on his study of various insulin regimens in type 2 diabetes.
In addition to financial and time barriers, patients encounter an array of problems that interfere with their achieving optimal control of their diabetes.
Several strategies may help patients incorporate lifestyle changes into their daily lives.
FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?
How can we encourage academic and community physicians to fill gaps in health care?
Edward C. Chao, DO, highlights important considerations for developing technology for diabetes management.
Joan K. Bardsley, MBA, RN, CDE, describes a joint position statement regarding implementation of diabetes self-management education.
Diabetes educators can help patients with obesity achieve long-term weight loss and prevent gaining it back.
The Holy Grail of health care is delivery of quality care at a reduced cost. But what exactly is quality care? How do we really know we are cutting costs?
Joan K. Bardsley, MBA, RN, CDE, FAADE, offers her perspective on the current state of health care and what needs to change.
Joan K. Bardsley, MBA, RN, CDE, discusses the theme of this year's annual meeting of the Association of Diabetes Educators.
What tools or techniques can we offer our patients to facilitate starting and sustaining adherence?
A change in how patients and physicians view diabetes may is necessary for preventing the disease and its complications.
Sometimes the most frustrating patients, the so-called "non-adherent" ones, can teach us how to improve diabetes care.
Data show that only 26% of physicians and 30% of nurses report episodes of workplace violence.
Data on cardiovascular benefits as well as adverse effects have thrust this class of diabetes drugs into the spotlight.
Researchers and clinicians must work to adopt strategies to integrate findings from clinical research into patient care.
The explosion of technological advances in the medical field poses challenges, including cybersecurity and potentially new malpractice claims.
The Conversation Map tools help incorporate guidelines to help clinicians individualize diabetes management.
Diabetes self-management education is an important aspect of diabetes care, and clinicians need to increase its use.
Focusing on what the patient does right is most beneficial in diabetes management.
AADE, ADA and AND released position statement on when a patient should be referred for diabetes self-management education.
A systematic review of evidence may help answer question of whether DSME benefits patients with diabetes.
Women seeking relief from menopausal symptoms must be aware of the risks, benefits of different treatment options.
Ann Albright, RD, PhD, of the CDC, discusses components of the National DPP.
Embracing new technologies can revolutionize health care and help engage patients in their own care.
Using technology to engage patients with diabetes is important in the changing landscape of health information.
Jennifer N. Clements, PharmD, BPCS, CDE, BCACP, reviews some details of the reports of ketocacidosis with the use of SGLT2 inhibitors.
One study demonstrating increased mortality among patients with type 1 diabetes implicates the importance of glycemic control.
Reflections on the drug may raise questions about when to use pramlintide in diabetes.
Rajiv Narayan, MSc, offers his thoughts on the special series on obesity published in The Lancet and what changes are necessary to fight the disease.
Jennifer N. Clements, PharmD, BCPS, CDE, BCACP, discusses the pros and cons of liraglutide as a new therapy for weight management.
Clinicians should bear some concerns in mind when following the Endocrine Society's recommendations on pharmacological management of obesity.
Richard T. Kloos, MD, discusses new technologies and methods for diagnosis of thyroid nodules.
Rajiv Narayan, MSc, discusses the top 10 abstracts presented at Obesity Week 2014.
Robert W Lash, MD, of the Endocrine Society, finds this study interesting and useful, but not a stinging indictment of acarbose.
A new ADA and EASD position statement along with the ADA's revised Standards of Medical Care in Diabetes have surprising updates.
Adequate iodine nutrition is essential for production of thyroid hormones, but many patients harbor misperceptions about iodine intake.
Evidence shows that the maximum dose of Qsymia is effective for obese patients with type 2 diabetes, but clinicians should still consider all factors.
The Endocrine Society is urging Congress to address shrinking federal budgets that may hinder groundbreaking medical research.
Young female athletes my experience endocrine disorders, including menstrual problems and difficulty with bone mass, due to intense training.
Kenneth D. Burman, MD, discusses one study suggesting that the optimal time for repeat evaluation of benign thyroid nodules is 2 to 4 years.
The first step in reducing the risk for cardiovascular disease is for health care professionals to get a full understanding of a patient's risk.
The Menopause Map facilitates discussion between patients and providers on the "menopause journey."
Study showing increased GH use among teens may have inherent flaws.
Help patients direct their energy into positive behaviors to manage their diabetes.